← Latest papers
🧬 biology

Prolonged methionine restriction induces liver cancer persistence through RNA G-quadruplex-mediated translational inhibition of HNF4α

This study reveals that prolonged methionine restriction promotes liver cancer persistence by activating AMPK to disrupt SRSF1-mediated translation of HNF4α via RNA G-quadruplexes, thereby driving a phenotypic shift to drug-tolerant mesenchymal cells.

Original authors: Xiaoling Li, Qing Xu, Yi Fang, Igor Shats, Naiduwadura De Silva, Dinushi Gamagedara, Jian-Liang Li, Jun Zhang

Published 2026-09-21
📖 6 min read🧠 Deep dive

Original authors: Xiaoling Li, Qing Xu, Yi Fang, Igor Shats, Naiduwadura De Silva, Dinushi Gamagedara, Jian-Liang Li, Jun Zhang

Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). ⚕️ This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer

Cancer is a disease of survival, but not always in the way we hope. While modern medicine has developed powerful tools to stop tumors, cancer cells are masters of adaptation. They can endure starvation, resist poison, and hide in plain sight, waiting for the right moment to return. One promising strategy to starve these cells involves limiting their intake of methionine, an essential building block that cells need to make proteins and protect themselves. For years, scientists have known that cutting off this nutrient can slow down tumor growth and make cancer cells more vulnerable to chemotherapy. However, a critical question remained unanswered: what happens if this dietary restriction continues for a long time? Does the cancer simply die, or does it evolve a new way to survive? Understanding this long-term response is vital, because if the treatment inadvertently teaches the cancer how to become tougher, the strategy could fail when it is needed most.

Researchers at the National Institute of Environmental Health Sciences set out to answer this question by watching how human liver cancer cells reacted to a diet severely lacking in methionine. They grew these cells in a laboratory dish with a nutrient level so low that it mimics a state of extreme hunger. Initially, the cells slowed down, as expected. But after several days, a small group of them did not just survive; they changed. These surviving cells stopped growing rapidly, stopped making proteins at their usual rate, and began to look and act like a different type of cell entirely. They became more mobile, more resistant to standard cancer drugs, and harder to kill. The scientists discovered that this transformation was not a random accident but a specific, programmed response driven by a molecular switch inside the cells.

The key to this switch was a protein called HNF4α, which acts as a master manager for liver cells, telling them to stay in their specialized, healthy state. The researchers found that the prolonged lack of methionine caused the cells to stop making this manager protein, even though the instructions to make it were still present in the cell's DNA. Without HNF4α, the liver cancer cells lost their identity and shifted into a survival mode that allowed them to persist through the starvation. This shift turned them into what scientists call "persister" cells: a dormant, tough population that can withstand treatment and eventually cause the cancer to return. The study showed that if the researchers forced these surviving cells to make HNF4α again, the cells became sensitive to the starvation diet once more, proving that the loss of this single protein was the direct cause of their newfound resistance.

The mechanism behind this loss of protein was surprisingly intricate. The researchers traced the problem to a specific structure within the instructions for making HNF4α. Inside the cell, the genetic code is read like a book, but sometimes the text folds into a complex knot called an RNA G-quadruplex. In this case, the instructions for HNF4α contained such a knot, which normally blocks the cell's machinery from reading the message and building the protein. Under normal conditions, a helper protein called SRSF1 acts like a pair of hands, binding to the knot and smoothing it out so the message can be read. However, when the cells were starved of methionine, a stress sensor inside the cell called AMPK became active. This sensor phosphorylated the helper protein SRSF1, essentially changing its shape so it could no longer grab onto the knot. With the helper protein unable to do its job, the knot remained tight, the instructions for HNF4α stayed unread, and the protein was never made.

This discovery reveals a hidden pathway where a lack of food triggers a chain reaction that alters the very identity of a cancer cell. The researchers confirmed that this process was not just a general slowdown of all protein production, but a targeted suppression of HNF4α caused by the specific folding of its genetic instructions. They also found that this same stress sensor, AMPK, was the driver of the change. When they blocked AMPK or replaced the helper protein with a version that could not be stopped by the stress signal, the cells could no longer form the resistant persisters. The study suggests that the cancer cells are not just passively waiting out the starvation; they are actively reprogramming themselves using a sophisticated molecular mechanism that links energy levels to the structure of genetic messages.

The implications of this finding extend beyond the laboratory. The researchers looked at data from patients with breast, rectal, and esophageal cancers who had undergone treatment. They found that the same genetic patterns seen in the starved liver cancer cells—specifically, the loss of HNF4α and the rise of survival traits—were present in the remaining tumor tissue after chemotherapy. This suggests that the adaptive response observed in the dish is a real phenomenon that occurs in human patients, potentially explaining why some cancers return after treatment. The study does not claim that methionine restriction is a failed treatment, but it highlights a critical risk: if the diet is applied for too long without interruption, it might select for the very cells that are hardest to kill.

By identifying the specific molecular players involved, the researchers have opened a new door for potential therapies. The connection between the stress sensor, the helper protein, and the knotted genetic instructions offers a new target. If doctors could block the stress sensor or prevent the helper protein from being disabled, they might be able to stop the cancer cells from shifting into this resistant state. The study emphasizes that understanding how cancer cells adapt to stress is just as important as knowing how to kill them. It paints a picture of cancer not as a static enemy, but as a dynamic system that constantly rewrites its own rules to survive, and it suggests that to defeat it, we must understand the rules it uses to change. The work provides a clear, concrete example of how a simple lack of nutrients can trigger a complex biological transformation, turning a vulnerable cell into a persistent one through the precise folding and unfolding of genetic material.

Drowning in papers in your field?

Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.

Try Digest →